GMI

Oral silibinin, an IGF-1 binder, may result in lowered IGF-1 levels in liver and colorectal cancer patients as indicated by its accumulation in blood and tissue samples.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *